These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12760889)

  • 1. Vancomycin penetration of uninfected pleural fluid exudate after continuous or intermittent infusion.
    Byl B; Jacobs F; Wallemacq P; Rossi C; de Francquen P; Cappello M; Leal T; Thys JP
    Antimicrob Agents Chemother; 2003 Jun; 47(6):2015-7. PubMed ID: 12760889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and prospective validation of a dosing instrument for continuous infusion of vancomycin: a within-population approach.
    van Maarseveen EM; Bouma A; Touw DJ; Neef C; van Zanten AR
    Eur J Clin Pharmacol; 2014 Nov; 70(11):1353-9. PubMed ID: 25168621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of method of antibiotic administration on pleural exudate penetration: a study of aztreonam given by rapid injection and constant infusion.
    Miglioli PA; Pivetta P; Fantoni U
    J Chemother; 1989 Jul; 1(4 Suppl):539-41. PubMed ID: 16312522
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of continuous infusion versus intermittent infusion of vancomycin in patients with methicillin-resistant Staphylococcus aureus.
    Jaruratanasirikul S; Julamanee J; Sudsai T; Saengsuwan P; Jullangkoon M; Ingviya N; Jarumanokul R
    J Med Assoc Thai; 2010 Feb; 93(2):172-6. PubMed ID: 20301996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentrations of vancomycin in human bone.
    Borner K; Hahn F; Koeppe P
    J Chemother; 1989 Jul; 1(4 Suppl):588-9. PubMed ID: 16312546
    [No Abstract]   [Full Text] [Related]  

  • 6. Penetration of vancomycin into human lung tissue.
    Cruciani M; Gatti G; Lazzarini L; Furlan G; Broccali G; Malena M; Franchini C; Concia E
    J Antimicrob Chemother; 1996 Nov; 38(5):865-9. PubMed ID: 8961057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switching From Intermittent to Continuous Infusion of Vancomycin in Critically Ill Patients: Toward a More Robust Exposure.
    van Maarseveen EM; Gipmans S; Vasbinder E; Petjak M; van Zanten AR
    Ther Drug Monit; 2016 Jun; 38(3):398-401. PubMed ID: 26926670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinectics of vancomycin and amikacin in the subeschar tissue fluid in patients with severe burn.
    Yang RH; Rong XZ; Hua R; Zhang T
    Burns; 2009 Feb; 35(1):75-9. PubMed ID: 18789586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous infusion of vancomycin less effective and safe than intermittent infusion, based on pharmacodynamic and pharmacokinetic principles.
    Panday PN; Sturkenboom M
    Clin Infect Dis; 2009 Dec; 49(12):1964-5; author reply 1965. PubMed ID: 19929398
    [No Abstract]   [Full Text] [Related]  

  • 10. Continuous intravenous administration of vancomycin in medical intensive care unit patients.
    Saugel B; Nowack MC; Hapfelmeier A; Umgelter A; Schultheiss C; Thies P; Phillip V; Eyer F; Schmid RM; Huber W
    J Crit Care; 2013 Feb; 28(1):9-13. PubMed ID: 22459156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Continuous and intermittent infusion of vancomycin equally effective: review of the literature].
    van Maarseveen EM; Man WH; Touw DJ; Bouma AW; van Zanten AR
    Ned Tijdschr Geneeskd; 2011; 155(42):A2667. PubMed ID: 22027450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A higher dose of vancomycin in continuous infusion is needed in critically ill patients.
    Jeurissen A; Sluyts I; Rutsaert R
    Int J Antimicrob Agents; 2011 Jan; 37(1):75-7. PubMed ID: 21074374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Continuous Infusion Vancomycin Administration in a Critically Ill Trauma Population.
    Bissell BD; Riggi G; Morrison C
    J Intensive Care Med; 2020 Jun; 35(6):570-575. PubMed ID: 29642744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive performance of pharmacokinetic models for outpatients receiving vancomycin continuous infusion.
    Ng TM; Lye DC; Chan M; Tam VH
    Int J Antimicrob Agents; 2014 Feb; 43(2):197-9. PubMed ID: 24359843
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics and tissue penetration of vancomycin continuous infusion as prophylaxis for vascular surgery.
    Payne CJ; Thomson AH; Stearns AT; Watson DG; Zhang T; Kingsmore DB; Byrne DS; Binning AS
    J Antimicrob Chemother; 2011 Nov; 66(11):2624-7. PubMed ID: 21840937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.
    Waineo MF; Kuhn TC; Brown DL
    J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of vancomycin on renal function in critically ill patients after cardiac surgery: continuous versus intermittent infusion.
    Hutschala D; Kinstner C; Skhirdladze K; Thalhammer F; Müller M; Tschernko E
    Anesthesiology; 2009 Aug; 111(2):356-65. PubMed ID: 19602966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on vancomycin dosing and monitoring practices in hemodialysis patients.
    Zhang M; Dresser L; Battistella M
    CANNT J; 2013; 23(4):25-7; quiz 28-9. PubMed ID: 24660521
    [No Abstract]   [Full Text] [Related]  

  • 19. Importance of vancomycin loading doses in intermittent infusion regimens.
    Šíma M; Hartinger J; Cikánková T; Slanař O
    J Infect Chemother; 2018 Apr; 24(4):247-250. PubMed ID: 29195829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Making the change to area under the curve-based vancomycin dosing.
    Heil EL; Claeys KC; Mynatt RP; Hopkins TL; Brade K; Watt I; Rybak MJ; Pogue JM
    Am J Health Syst Pharm; 2018 Dec; 75(24):1986-1995. PubMed ID: 30333114
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.